FC

Fem Care Pharma Ltd(merged)

524608 BSE
This stock has been delisted or merged and is no longer actively traded.
Price unavailable

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

1
  • Company has a good return on equity (ROE) track record: 3 Years ROE 42.3%

Technical Indicators

Oscillators

BearishNeutralBullish

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

BearishNeutralBullish

Neutral

Bearish
6
Neutral
7
Bullish
6

Moving Averages

BearishNeutralBullish

Bullish

Bearish
4
Neutral
0
Bullish
6

Growth Rate

Revenue Growth
15% level than 3Y

change over 1 year

Net Income Growth
12% lower than 3Y

change over 1 year

Quarterly Results

Particulars Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Jun 2025Sep 2025Dec 2025
Sales
45.25
47.17
17.22
28.15
30.04
23.09
16.99
13.39
16.19
0.69
0
0
0
Expenses
34.48
32.7
31.06
24.72
27.72
22.53
15.34
10.54
12.99
0.94
0.22
0.26
0.19
Operating Profit
10.77
14.47
-13.84
3.43
2.32
0.56
1.65
2.85
3.2
-0.25
-0.22
-0.26
-0.19
OPM %
23.8%
30.68%
-80.37%
12.18%
7.72%
2.43%
9.71%
21.28%
19.77%
-36.23%
—
—
—
Other Income
0
0
0
5.13
0
0
-0.92
0
0.04
0.05
0
0
0
Interest
0.14
0.15
0.15
0.04
0
0
0
0
0
0
0
0
0
Depreciation
0.17
0.13
0.13
0.14
0.13
0.12
0.1
0.07
0
0
0
0
0
PBT
10.46
14.19
-14.12
8.38
2.19
0.44
0.63
2.78
3.24
-0.2
-0.22
-0.26
-0.19
Tax %
25.53%
25.23%
-24.43%
25.3%
26.48%
27.27%
119.05%
25.9%
0%
0%
0%
0%
0%
Net Profit
7.79
10.61
-10.67
6.25
1.62
0.32
-0.12
2.06
3.24
-0.2
-0.22
-0.26
-0.19
EPS (₹)
0.71
0.97
-0.98
0.57
0.15
0.03
-0.01
0.13
0.2
-0.01
-0.01
-0.02
-0.01
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2006Mar 2007Mar 2008Mar 2009
Sales
70
81
94
107
Expenses
59
65
80
92
Operating Profit
11
16
14
16
OPM %
16%
20%
15%
15%
Other Income
1
1
-2
0
Interest
0
0
1
1
Depreciation
1
2
2
3
PBT
12
16
9
12
Tax %
40%
27%
13%
14%
Net Profit
7
11
8
11
EPS (₹)
—
—
—
30.43
Div. Payout %
27%
27%
26%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2006Mar 2007Mar 2008Mar 2009
Equity Capital
3
3
3
4
Reserves
13
19
25
36
Borrowings
3
3
18
19
Other Liabilities
25
33
20
20
Total Liabilities
44
58
65
78
Fixed Assets
11
21
34
33
CWIP
10
5
1
0
Investments
1
0
2
9
Other Assets
22
33
29
35
Total Assets
44
58
65
78
Figures in ₹ Crores

Cash Flow

Particulars Mar 2006Mar 2007Mar 2008Mar 2009
Operating
10
6
12
18
Investing
-7
-5
-17
-10
Financing
-1
-2
9
-6
Net Cash Flow
1
-1
4
2
Free Cash Flow
2
-1
0
15
CFO/OP
122
62
99
123
Figures in ₹ Crores

Ratios

Particulars Mar 2006Mar 2007Mar 2008Mar 2009
Debtor Days
21
17
19
23
Inventory Days
71
162
107
97
Days Payable
122
100
99
84
Cash Conversion Cycle
-30
78
27
36
Working Capital Days
-31
3
18
27
ROCE %
—
68%
35%
29%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Fem Care Pharma Ltd(merged) insights

29 extracted metrics + investor summaries across FY06–FY26.

Log in — free

Shareholding Pattern

Public90.59%Promot.9.41%As ofMar 2025

Documents

Frequently Asked Questions about Fem Care Pharma Ltd(merged)

Where is Fem Care Pharma Ltd(merged) (524608) listed?
Fem Care Pharma Ltd(merged) trades under code 524608 on the BSE.

Company Information

Website femcareworld.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524608.md for Fem Care Pharma Ltd(merged): company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List